Search for: "BIOGEN IDEC U.S."
Results 21 - 40
of 69
Sorted by Relevance
|
Sort by Date
13 Apr 2009, 6:28 am
" The effects of Raptiva decrease the function of the immune system and increase susceptibility to infections (incidentally, PML is the same disease that has been linked to the multiple sclerosis drug Tysabri, sold by Biogen Idec and Elan). [read post]
23 Mar 2007, 9:47 am
LEDERMAN, 355 F.3d 1343, 69 U.S.P.Q.2D 1508 (CAFC 2004), wherein Biogen and Idec were fighting over discoveries made with federal funding. [read post]
31 May 2018, 3:02 pm
Spencer [ Pharm Pat Anal. 2014 Mar;3(2):183-98 ] discloses part of the history of Tecfidera and shows that issuesother than patent protection delay entrance of competitors:As a case study of patent coverage for a repurposed drug, Biogen Idec's approach for Tecfidera(®),an oral formulation of dimethyl fumarate, was analyzed. [read post]
24 Aug 2011, 6:26 am
Cambridge was praised for the strong network of bicycle lanes and shared lane space along the Massachusetts institute of Technology (MIT) campus and nearby technology companies, such as Genzyme, Sanofi Aventies, Biogen Idec and Akamai. [read post]
5 Jul 2010, 11:19 am
Biogen Idec – to the Federal Circuit to reconsider the cases in light of the Bilski decision. [read post]
19 Apr 2013, 9:25 pm
Biogen Idec Inc., C.A. [read post]
21 Apr 2009, 2:20 pm
We get some insightful additional information from a Dow Jones article, "Biogen Says Sixth MS Patient On Tysabri Gets Brain Infection": Tysabri - sold by the Cambridge, Mass., biotech [Biogen Idec Inc. [read post]
6 Sep 2011, 1:10 pm
Biogen IDEC et al. (08-1509). [read post]
3 Nov 2011, 12:48 pm
Biogen IDEC, and CyberSource Corp. v. [read post]
22 Mar 2016, 6:12 am
.* The U.S. [read post]
15 Sep 2010, 8:39 am
Biogen Idec (method of determining an immunization schedule) and Association for Molecular Pathology v. [read post]
3 Mar 2017, 8:32 am
Biogen Idec, Inc. v. [read post]
10 Jun 2010, 3:58 am
(Patent Docs) Avonex (Interferon) – US: Biogen launches submarine patent against competing providers of Interferon-Beta products: Biogen Idec MA Inc. v. [read post]
1 Sep 2011, 8:31 am
Biogen Idec. [read post]
1 Sep 2011, 8:31 am
Biogen Idec. [read post]
22 Mar 2012, 4:55 am
Biogen Idec, 659 F.3d 1057 (Fed. [read post]
30 Mar 2012, 8:30 am
Biogen IDEC. [read post]
7 Aug 2012, 11:45 pm
Biogen IDEC, 659 F.3d 1057 (Fed. [read post]
13 Aug 2019, 7:34 pm
” Biogen Idec, Inc. v. [read post]
29 Jun 2010, 8:54 am
Biogen IDEC. [read post]
